Loading...

ISHITADR Ishita Drugs & Industries Ltd Changes in management or control Announcement

sht

SHTD

Ishita Drugs & Industries Ltd

(ISHITADR)

2025 Announcement

Related party acquisition

Related party acquisition

Related Party Transaction

Disclosure under SEBI SAST ...

Related Party Acquisition

Related party acquisition

Equity Investment

Related Party Acquisition

Unaudited Financial Results

Board approved results

Board Meeting Notice

Compliance Certificate

Auditor Appointment

Management Change

Share Acquisition

Share Acquisition

Share Acquisition

Share Acquisition

Share Acquisition

Management Change

Compliance Confirmation

Share Acquisition

Facility Upgrade

Management Change

Regulation Non Applicability

Compliance Update

Compliance Certificate

Compliance Confirmation

Share Acquisition

Compliance Certificate

Share Acquisition

Share Acquisition

Share Acquisition

Management Change

Regulatory Compliance

Management Changes

Statutory Auditor Appointment

Management Change

Confirmation Certificate Su...

Promoter Acquisition

Acquisition of Shares

Regulation Non-Applicability

Annual Compliance Report No...

Compliance Certificate Subm...

Compliance Certificate Subm...

Certificate Submission

Revised AGM Proceedings

Disclosure Update

Acquisition of Shares

Confirmation Certificate

Confirmation Certificate

Appointment of Statutory Au...

Management Changes

Regulatory Compliance

External Links:

Data:

Ishita Drugs & Industries Ltd has re-appointed Mr. Arvind Vilasrao Sapkal as a non-executive independent director for a second term of five years, pending shareholder approval, during a board meeting on August 12, 2025.

AI Assistant

Ishita Drugs & Industries Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.